Related Experiment Video
Updated: Mar 12, 2026

An Integrated System to Remotely Trigger Intracellular Signal Transduction by Upconversion Nanoparticle-mediated Kinase Photoactivation
Published on: August 30, 2017
Near-infrared uncaging or photosensitizing dictated by oxygen tension
Erin D Anderson1, Alexander P Gorka1, Martin J Schnermann1
1Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, USA.
Abstract:
Existing strategies that use tissue-penetrant near-infrared light for the targeted treatment of cancer typically rely on the local generation of reactive oxygen species. This approach can be impeded by hypoxia, which frequently occurs in tumour microenvironments. Here we demonstrate that axially unsymmetrical silicon phthalocyanines uncage small molecules preferentially in a low-oxygen environment, while efficiently generating reactive oxygen species in normoxic conditions. Mechanistic studies of the uncaging reaction implicate a photoredox pathway involving photoinduced electron transfer to generate a key radical anion intermediate. Cellular studies demonstrate that the biological mechanism of action is O2-dependent, with reactive oxygen species-mediated phototoxicity in normoxic conditions and small molecule uncaging in hypoxia. These studies provide a near-infrared light-targeted treatment strategy with the potential to address the complex tumour landscape through two distinct mechanisms that vary in response to the local O2 environment.
Insights
New silicon phthalocyanines offer dual-action cancer therapy. They generate reactive oxygen species in normal oxygen and release drugs in low-oxygen tumor environments, overcoming treatment limitations.
Area of Science:
- Photochemistry
- Cancer Therapeutics
- Biomedical Engineering
Background:
- Current near-infrared light cancer therapies often fail in hypoxic tumor microenvironments due to reliance on reactive oxygen species generation.
- Hypoxia is a common challenge in solid tumors, limiting the efficacy of many cancer treatments.
Purpose of the Study:
- To develop a novel near-infrared light-activated therapeutic strategy that functions effectively in both normoxic and hypoxic tumor conditions.
- To investigate silicon phthalocyanine-based photosensitizers capable of dual-mode action dependent on oxygen levels.
Main Methods:
- Synthesis and characterization of axially unsymmetrical silicon phthalocyanines.
- Investigation of photoredox pathways and photoinduced electron transfer mechanisms for small molecule uncaging.
- Cellular studies to assess O2-dependent biological activity, including reactive oxygen species generation and drug release.
Main Results:
- Axially unsymmetrical silicon phthalocyanines were shown to uncage small molecules preferentially in low-oxygen environments.
- These compounds efficiently generate reactive oxygen species under normoxic conditions.
- The mechanism involves a photoredox pathway with a key radical anion intermediate, and cellular studies confirmed O2-dependent phototoxicity and drug release.
Conclusions:
- Developed a versatile near-infrared light-targeted cancer treatment adaptable to varying tumor oxygen levels.
- The dual-mechanism approach, utilizing reactive oxygen species in normoxia and small molecule release in hypoxia, offers a promising strategy for complex tumor landscapes.
- This O2-responsive system enhances the potential of photodynamic and photopharmacological cancer therapies.
Related Concept Videos
Oxygenic Photosynthesis
UV–Vis Spectroscopy: Molecular Electronic Transitions
The Photochemical Reaction Center
Anoxygenic Photosynthesis
Photoreceptors and Visual Pathways

